Latest news
What we want from NhWes
Thank you to everyone who wrote to their Labour MP asking them to come and see us at our stand at the Labour Party Conference. We were inundated with MPs wanting to find out more about epilepsy and support our campaigns as a result of your invitations. This will really help to amplify the voices of people with epilepsy in parliament.
New data report shows significant drop in valproate prescriptions
The latest Clinical Practice Research Datalink (CPRD) published this month by the Medicines and Healthcare Products Regulatory Agency (MHRA) shows a significant drop in valproate being newly prescribed to females and males between January 2018 and June 2024.
Fix it For Free
With the government pledging to review the NHS dental contract, Epilepsy Society is asking for a medical exemption from fees for people with epilepsy who damage their teeth as the result of a seizure. Between 50,000 and 100,000 people are affected and living with broken and damaged teeth.
Death of the Duchess of Kent
We are deeply saddened to hear of the passing of Her Royal Highness, The Duchess of Kent. Our own Kent House, which is now the Epilepsy Society's training centre was named in her honour.
New research suggests similar brain patterns in seizure-linked psychosis and schizophrenia
Latest research at the Epilepsy Society using pioneering research equipment has shown parallels between people with seizure-linked psychosis and schizophrenia.
Treatment for ultra-rare form of epilepsy shows promising results
A late-stage study has shown promising results for the effectiveness of fenfluramine in people with an ultra-rare form of epilepsy - CDKL5 deficiency disorder (CDD).
CDD affects approximately one in 40,000 to 60,000 live births. The disorder causes uncontrolled seizures and symptoms usually appear at six weeks of age, alongside learning and developmental issues.